NCT02037672View on ClinicalTrials.gov

PDE-4 Inhibitor Roflumilast and Polycystic Ovary Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

January 31, 2014

Conditions
PCOSObesity
Interventions
DRUG

metformin

DRUG

metformin and roflumilast

Trial Locations (1)

1000

University Medical Center Ljubljana, Ljubljana

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER

NCT02037672 - PDE-4 Inhibitor Roflumilast and Polycystic Ovary Syndrome | Biotech Hunter | Biotech Hunter